0.79 USD
↗ 0.01 (1.04%)AT CLOSE (03:59 PM EDT)
Biofrontera Inc. Common Stock
BFRINASDAQ • USD
0.79
↗ 0.00 (0.49%)
POST MARKET (AS OF 05:03 PM EDT)
Post Market
AS OF 05:03 PM EDT
0.79
↗ 0.00 (0.49%)
Market: CLOSED
BFRI is currently priced at $0.79. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Key drivers include a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation side, BFRI appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Oct 23, 2026.
Open?$0.80
High?$0.81
Low?$0.78
Prev. Close?$0.78
Volume?104.5K
Avg. Volume?427.9K
VWAP?$0.79
Rel. Volume?0.24x
Bid / Ask
Bid?$0.78 × 400
Ask?$0.81 × 200
Spread?$0.03
Midpoint?$0.80
Valuation & Ratios
Market Cap?11.7M
Shares Out?N/A
Float?11.3M
Float %?88.3%
P/E Ratio?N/A
P/B Ratio?1.97
EPS?-$0.43
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
Employees
94
Market Cap
11.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-10-29
Address
120 PRESIDENTIAL WAY,
WOBURN, MA 01801
Phone: 781-245-1325
WOBURN, MA 01801
Phone: 781-245-1325
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?0
Momentum?50
Short Sent.?100
Piotroski F-Score?5/9Mixed
Altman Z-Score?-6.25Distress
Confidence?46%Low
Short InterestLow
Short % of Float?1.30%Low
Short Interest?146.9K
Days to Cover?1.0
Free Float11.3M
Avg Daily Volume403.1K
Settlement Date2026-09-30
Financial Health
Current Ratio?1.18Adequate
Quick Ratio?1.08Adequate
Cash Ratio?0.44Low
Debt/Equity?0.78Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.97CHEAP▾
Peers100
S&P75
P/S?0.25CHEAP▾
Peers100
S&P97
P/FCF?N/A▾
EV/EBITDA?-1.8CHEAP▾
S&P97
EV/Sales?0.25CHEAP▾
Peers100
S&P97
Returns & Efficiency
ROE?-106.9%WEAK▾
S&P3
ROA?-26.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-7930000
Enterprise Value?$11.7M
Fundamentals ratios updated end of day